All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Suviray 70mg Injection
Prescription Required
Salt Composition : Erenumab
Manufacturer : NOVARTIS INDIA LTD
Origin of Medicine : Switzerland
1 Prefilled Syringe(s)
Introduction to Suviray 70mg Injection
Suviray 70 mg Injection contains an active component of Erenumab. It belongs to the class of medicines called monoclonal antibodies. This medication is used for the preventive treatment of migraines in abdults. Migraine is a neurological disorder characterized by recurring and intense headaches, often accompanied by other symptoms such as nausea, sensitivity to light, and visual disturbances. For individuals who have not responded well to or have contraindications to other migraine preventive medications, Suviray 70 mg Injection provides an alternative treatment option. It is not recommended to use this medicine if you are allergic to the active compound Suviray 70 mg Injection and its compounds. If you have a history of hypersensitivity reactions to biologic agents or other injectable treatments, you should discuss this with your healthcare provider before starting Suviray 70 mg Injection. It is not recommended to use in children and adolescents under 18 years old. The use in elderly individuals needs close monitoring.
Individuals with severe liver or kidney impairment may require dosage adjustments or careful monitoring when using this medication. It may have an effect on your blood pressure. Individuals with severe cardiovascular illnesses, such as uncontrolled hypertension or a history of heart attack, may need to monitor or change their treatment plan while using this medicine. If you develop serious constipation of new hypertension it is advised to see a healthcare professional. Pregnant women and nursing mothers are required to get their consultation prior to taking Suviray 70 mg Injection. It is advised to inform your healthcare provider about all the medicines you are taking including herbal, vitamin supplements and over the counter medicines before starting the treatment.
Uses of Suviray 70mg Injection
- Prevention of migraine in adults
Therapeutic Effects of Suviray 70mg Injection
Suviray 70 mg Injection works by targeting and inhibiting the calcitonin gene-related peptide (CGRP) receptor. This affects the signaling pathway responsible for sending pain signals and dilation of blood vessels, both of which contribute to the development of migraines. This blockade seeks to minimize the frequency and intensity of migraine attacks, providing a preventive approach to migraine management in adults.
Interaction of Suviray 70mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over the counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Suviray 70 mg Injection and reduce effectiveness by causing undesirable side effects.
More Information about Suviray 70mg Injection
- Store Suviray 70 mg Injection Tablet in the original package at room temperature (20°C to 25°C).
- Keep it out of reach from children
- Keep away from moisture, heat, and light.
- It should not be frozen.
How to consume Suviray 70mg Injection
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Suviray 70 mg Injection is administered as a subcutaneous injection. It is injected under the skin, typically in the abdomen or thigh area, once a month. This route of administration allows the medication to be absorbed into the bloodstream and exert its preventive effects on migraines over time. It's important to follow the proper injection technique and guidelines your healthcare provider provides to ensure the medication is administered correctly and safely.
Safety Advices for Suviray 70mg Injection
Pregnancy
It is generally advised to avoid using Suviray 70 mg Injection while pregnant unless the possible benefits outweigh the risks involved. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.
Breast Feeding
Consult your healthcare provider before using Suviray 70 mg Injection while breastfeeding. They will assess your situation, taking into account the severity of your migraines, available treatment alternatives, and potential risks to your nursing infant.
Lungs
Consult your doctor if you have any lung diseases before starting the treatment with Suviray 70 mg Injection.
Liver
Individuals with severe liver may require dosage adjustments or careful monitoring when using Suviray 70 mg Injection. Consult your healthcare provider before starting this medication.
Alcohol
Drinking too much alcohol may cause migraines or interfere with the effects of Suviray 70 mg Injection. For safety and efficacy, follow the advice of your healthcare provider.
Driving
Suviray 70 mg Injection does not have an impact on your ability to operate machinery and drive. See your healthcare provider before operating a vehicle if you suffer any side effects that could impair your ability to drive. When determining whether to drive after taking Suviray 70 mg Injection, put safety first.
Side Effects of Suviray 70mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common:
- Constipation
- Itching
- Vomiting
- Fatigue
- Nausea
- Muscle spasms
- Injection site reactions
Serious:
- Serious allergic reactions
- Chronic constipation
Word of Advice
You are advised to be cautious with overuse of pain-relieving medications, as frequent use of certain medications (e.g., opioids, triptans, NSAIDs) can lead to medication-overuse headaches. You should not skip meals for a longer time since low blood sugar levels can cause migraines in some cases. You are advised to eat foods rich in magnesium, omega 3 fatty acids and hydrating foods to cope with migraine pain.Use a migraine journal or smartphone app to record your migraine episodes, along with their causes, symptoms, and any trends that may emerge. Finding trends and triggers can help you better manage your disease.You should also maintain a quality sleep around 7-9 hours and proper hydration with 8-10 glasses of water per day to keep away migraines.
Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Suviray 70 mg Injection can be effective in migraine treatments.
FAQs
Q 1. How long does Suviray 70mg injection treatment last?
Suviray 70mg injection is typically administered as a monthly injection. Your healthcare provider will determine the appropriate duration of treatment based on your response and needs.
Q 2. Who should receive treatment with Suviray 70 mg Injection?
Adults who have four or more migraine days a month and have not responded well to or tolerated other preventative drugs may find Suviray 70 mg Injection to be a good option. To find out if Suviray 70 mg Injection is right for you, it's crucial to talk to your doctor about your migraine history and available treatments.
Q 3. Can Suviray 70mg injection cause weight gain?
Weight gain is not a commonly reported side effect of Suviray 70mg injection. However, individual responses to medications can vary. Consult your healthcare provider if you have concerns.
Q 4. Is Suviray 70mg injection suitable for all types of migraines?
Suviray 70mg injection is primarily indicated for the prevention of migraine attacks. Your healthcare provider will assess the type and frequency of your migraines to determine if Suviray 70mg injection is appropriate for you.
Q 5. What are Suviray 70 mg Injection's typical side effects?
Constipation, muscle cramps, and injection site reactions (such as redness, discomfort, and swelling) are common Suviray 70 mg Injection side effects. Although uncommon, serious allergic reactions can occur. Notifying your healthcare provider of any adverse effects as soon as possible is crucial.
Q 6. Can side effects worsen with higher Suviray 70mg injection doses?
Higher doses of Suviray 70mg injection are not typically associated with worsened side effects. Your healthcare provider will determine the appropriate dose based on your condition.
Fact Box of Suviray 70mg Injection
| Molecule Name: Erenumab | Therapeutic class: Migraine Prevention Agent |
Pharmacological class: Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist | Indications:
|
| Dosage form: Injection | Habit forming: No |
References
- Amgen Inc., United States Food and Drug Administration (USFDA), [Revised on February 2021], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761077s009lbl.pdf
- Novartis Pharmaceuticals UK Ltd, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.10297.pdf
- Anna P.Andreou et al; The role of erenumab in the treatment of migraine; Therapeutic Advances in Neurological Disorders, [Published on 27/05/2020] ,[Accessed on 23-04-2024], https://www.ncbi.nlm.nih.gov/pubmed/32523630
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
